
Shares of consumer health co Kenvue KVUE.N rise 1.20% to $23.60 premarket
TOMS Capital Investment Management has taken a stake in KVUE and is pushing for changes, Bloomberg News reported on Sunday
The New York-based hedge fund is urging KVUE to consider a full sale or separation of some assets, the report said according to people with knowledge of the matter
The size of TOMS' stake could not immediately be learned, the report added
Earlier this month, KVUE settled the proxy fight with activist Starboard and appointed three directors
Up to last close, stock up ~9% YTD